Takeda Pharmaceutical Company Limited
武田薬品工業株式会社

Japan

1 October 2019 - 30 September 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Takeda Pharmaceutical Company Limited published between 1 October 2019 - 30 September 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Count Share
20 4.25

Outputs by subject (Share)

Subject Count Share
Life Sciences 17 2.62
Chemistry 6 1.98

1 October 2019 - 30 September 2020

International vs. domestic collaboration by Share

  • 29.92% Domestic
  • 70.08% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (61 total)

  • Takeda Pharmaceutical Company Limited, Japan
  • Domestic institution
  1. Kyoto University, Japan (1.58)
    0.57
    1.01
  2. RIKEN, Japan (1.02)
    0.46
    0.56
  3. Kanazawa University (KU), Japan (1)
    0.29
    0.71
  4. National Institute of Advanced Industrial Science and Technology (AIST), Japan (0.82)
    0.01
    0.81
  5. Osaka University, Japan (0.64)
    0.17
    0.47
  6. Juntendo University, Japan (0.60)
    0.40
    0.20
  7. Yokohama City University (YCU), Japan (0.55)
    0.43
    0.12
  8. Japanese Foundation for Cancer Research (JFCR), Japan (0.47)
    0.18
    0.29
  9. Tokyo Medical and Dental University (TMDU), Japan (0.44)
    0.43
    0.01
  10. Osaka City University (OCU), Japan (0.25)
    0.17
    0.08

Top 10 international collaborators by Share (82 total)

  • Takeda Pharmaceutical Company Limited, Japan
  • Foreign institution
  1. Mount Sinai Health System (MSHS), United States of America (USA) (1.44)
    0.49
    0.95
  2. Yale University, United States of America (USA) (1.17)
    0.66
    0.52
  3. The University of Texas MD Anderson Cancer Center, United States of America (USA) (1.16)
    0.28
    0.88
  4. BioAnalytix, Inc., United States of America (USA) (1)
    0.75
    0.25
  5. University of Bristol (UoB), United Kingdom (UK) (0.93)
    0.33
    0.60
  6. University of Minnesota (UMN), United States of America (USA) (0.90)
    0.40
    0.50
  7. Amgen Inc., United States of America (USA) (0.74)
    0.01
    0.72
  8. Structural Genomics Consortium (SGC Toronto), Canada (0.62)
    0.26
    0.36
  9. University of Toronto (U of T), Canada (0.57)
    0.26
    0.31
  10. Harvard University, United States of America (USA) (0.52)
    0.13
    0.39

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Creative Commons License

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Return to institution outputs

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER